MRVL vs SRTS · P/E 100, rev $5.16B vs P/E 42, rev $5.7M
Marvell Technology Group Ltd (MRVL) versus Sensus Healthcare Inc (SRTS) — a side-by-side from cached financials, not a winner call.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ.
Sensus Healthcare Inc (SRTS) is a medical devices company listed on US.
Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Latest reported SRTS revenue for 2026-06-30 was $5.7M. Net income was -$11.4M. Revenue was up 67.5% from 2026-03-31 to 2026-06-30. SRTS currently screens at market cap $76.6M and trailing P/E 42.4.
MRVL currently screens at market cap $253.51B and trailing P/E 99.8. SRTS currently screens at market cap $76.6M and trailing P/E 42.4.
Not investment advice. Open the MRVL and SRTS stock pages for the full models.
Not investment advice.